WO2009041549A1 - 眼科用組成物 - Google Patents

眼科用組成物 Download PDF

Info

Publication number
WO2009041549A1
WO2009041549A1 PCT/JP2008/067378 JP2008067378W WO2009041549A1 WO 2009041549 A1 WO2009041549 A1 WO 2009041549A1 JP 2008067378 W JP2008067378 W JP 2008067378W WO 2009041549 A1 WO2009041549 A1 WO 2009041549A1
Authority
WO
WIPO (PCT)
Prior art keywords
ophthalmic composition
intended
polymer compound
contact lenses
base polymer
Prior art date
Application number
PCT/JP2008/067378
Other languages
English (en)
French (fr)
Inventor
Yasuko Matsumura
Kazuhiro Fukushima
Original Assignee
Rohto Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co., Ltd. filed Critical Rohto Pharmaceutical Co., Ltd.
Priority to US12/680,318 priority Critical patent/US20100249062A1/en
Priority to JP2009534392A priority patent/JP5349317B2/ja
Publication of WO2009041549A1 publication Critical patent/WO2009041549A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

　本発明はコンタクトレンズ装用中の涙液層を安定化させ、目の乾きを抑制し、使用感が良く、かつ利便性に優れ、誤用の心配が無く、製造から販売までの段階での効率性の高い眼科用組成物を提供する。より詳細には、本発明は、（Ａ）セルロース系高分子化合物、ビニル系高分子化合物、ポリエチレングリコール、デキストランからなる群より選択される１種以上、及び（Ｂ）ブドウ糖を含有するコンタクトレンズ用装着点眼液を提供する。
PCT/JP2008/067378 2007-09-28 2008-09-26 眼科用組成物 WO2009041549A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/680,318 US20100249062A1 (en) 2007-09-28 2008-09-26 Ophthalmic composition
JP2009534392A JP5349317B2 (ja) 2007-09-28 2008-09-26 眼科用組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007-254768 2007-09-28
JP2007254768 2007-09-28
JP2008020974 2008-01-31
JP2008-020974 2008-01-31

Publications (1)

Publication Number Publication Date
WO2009041549A1 true WO2009041549A1 (ja) 2009-04-02

Family

ID=40511429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/067378 WO2009041549A1 (ja) 2007-09-28 2008-09-26 眼科用組成物

Country Status (3)

Country Link
US (1) US20100249062A1 (ja)
JP (1) JP5349317B2 (ja)
WO (1) WO2009041549A1 (ja)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011006348A (ja) * 2009-06-25 2011-01-13 Lion Corp ドライアイ治療剤
WO2011040433A1 (ja) * 2009-09-30 2011-04-07 ロート製薬株式会社 点眼剤
JP2014136684A (ja) * 2013-01-16 2014-07-28 Toray Ind Inc 液剤
US9119827B2 (en) 2009-06-30 2015-09-01 Lion Corporation Ophthalmic composition
JP2017178880A (ja) * 2016-03-31 2017-10-05 佐賀製薬株式会社 人工涙液型点眼剤組成物
JP2018203723A (ja) * 2017-05-30 2018-12-27 ロート製薬株式会社 摩擦低減用であるコンタクトレンズ用点眼剤、その使用方法、および装用中のコンタクトレンズの摩擦低減方法
JP2019142979A (ja) * 2012-09-27 2019-08-29 千寿製薬株式会社 水性液剤

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013026534A2 (pt) * 2011-04-22 2016-12-27 Alcon Res Ltd composição oftálmica com um sistema de realce da viscosidade tendo dois diferentes agentes de realce da viscosidade
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
US10174006B2 (en) * 2013-06-06 2019-01-08 Novartis Ag Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
WO2021107033A1 (ja) * 2019-11-29 2021-06-03 千寿製薬株式会社 医薬組成物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001261578A (ja) * 2000-03-16 2001-09-26 Lion Corp 眼科用組成物
JP2005172912A (ja) * 2003-12-08 2005-06-30 Lion Corp ソフトコンタクトレンズの装着方法及び装着液原液、並びにコンタクトレンズキット
JP2005187345A (ja) * 2003-12-24 2005-07-14 Lion Corp コンタクトレンズ装着液
JP2006022087A (ja) * 2004-06-08 2006-01-26 Rohto Pharmaceut Co Ltd 眼科用清涼組成物
WO2006009101A1 (ja) * 2004-07-21 2006-01-26 Senju Pharmaceutical Co, .Ltd. コンタクトレンズ用装着液
WO2006105183A1 (en) * 2005-03-31 2006-10-05 Johnson & Johnson Vision Care, Inc. Methods of inspecting ophthalmic lenses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1558597A (en) * 1996-02-07 1997-08-28 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition with regulated viscosity
JP5649261B2 (ja) * 2004-05-07 2015-01-07 ロート製薬株式会社 高粘度点眼剤

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001261578A (ja) * 2000-03-16 2001-09-26 Lion Corp 眼科用組成物
JP2005172912A (ja) * 2003-12-08 2005-06-30 Lion Corp ソフトコンタクトレンズの装着方法及び装着液原液、並びにコンタクトレンズキット
JP2005187345A (ja) * 2003-12-24 2005-07-14 Lion Corp コンタクトレンズ装着液
JP2006022087A (ja) * 2004-06-08 2006-01-26 Rohto Pharmaceut Co Ltd 眼科用清涼組成物
WO2006009101A1 (ja) * 2004-07-21 2006-01-26 Senju Pharmaceutical Co, .Ltd. コンタクトレンズ用装着液
WO2006105183A1 (en) * 2005-03-31 2006-10-05 Johnson & Johnson Vision Care, Inc. Methods of inspecting ophthalmic lenses

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011006348A (ja) * 2009-06-25 2011-01-13 Lion Corp ドライアイ治療剤
US9119827B2 (en) 2009-06-30 2015-09-01 Lion Corporation Ophthalmic composition
WO2011040433A1 (ja) * 2009-09-30 2011-04-07 ロート製薬株式会社 点眼剤
JP2011093888A (ja) * 2009-09-30 2011-05-12 Rohto Pharmaceutical Co Ltd 点眼剤
CN102548582A (zh) * 2009-09-30 2012-07-04 乐敦制药株式会社 滴眼剂
CN102548582B (zh) * 2009-09-30 2015-09-02 乐敦制药株式会社 滴眼剂
US9278062B2 (en) 2009-09-30 2016-03-08 Rohto Pharmaceutical Co., Ltd. Eye drops
JP2019142979A (ja) * 2012-09-27 2019-08-29 千寿製薬株式会社 水性液剤
JP2014136684A (ja) * 2013-01-16 2014-07-28 Toray Ind Inc 液剤
JP2017178880A (ja) * 2016-03-31 2017-10-05 佐賀製薬株式会社 人工涙液型点眼剤組成物
JP2018203723A (ja) * 2017-05-30 2018-12-27 ロート製薬株式会社 摩擦低減用であるコンタクトレンズ用点眼剤、その使用方法、および装用中のコンタクトレンズの摩擦低減方法

Also Published As

Publication number Publication date
US20100249062A1 (en) 2010-09-30
JP5349317B2 (ja) 2013-11-20
JPWO2009041549A1 (ja) 2011-01-27

Similar Documents

Publication Publication Date Title
WO2009035034A1 (ja) 眼科用組成物
WO2009041549A1 (ja) 眼科用組成物
WO2009035033A1 (ja) 眼科用組成物
WO2009140080A3 (en) Intraocular lens having extended depth of focus
WO2007147152A3 (en) High visual acuity contact lenses
WO2006063139A3 (en) Nanohybrid polymers for ophthalmic applications
WO2007146365A3 (en) Decreased lens delamination during ophthalmic lens manufacture
WO2004063773A3 (en) Contact lenses with blended microchannels
WO2008063874A3 (en) Electro-active ophthalmic lens having an optical power blending region
WO2007133384A3 (en) Aspheric multifocal diffractive ophthalmic lens
WO2009100257A3 (en) Compound micro lens implant
ATE537717T1 (de) Schutzbrillen
WO2009072528A1 (ja) 一対の累進屈折力レンズ及びその設計方法
WO2011063287A3 (en) Face protector lens assembly and method of use
WO2011037893A3 (en) Wettable hydrogel materials for use in ophthalmic applications and methods
WO2009057709A1 (ja) 眼鏡レンズ評価方法、これを用いた眼鏡レンズ設計方法、眼鏡レンズ製造方法、眼鏡レンズ製造システム及び眼鏡レンズ
WO2006113595A3 (en) Implantable lenses with modified edge regions
BRPI0912521B8 (pt) dispositivo oftálmico
WO2007124476A3 (en) Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
WO2009088448A3 (en) Intraocular, accomodating lens and methods of use
WO2006124198A8 (en) Aspherical diffractive ophthalmic lens
WO2009111545A3 (en) Rotationally stabilized contact lenses and methods for their design
WO2009130610A3 (en) Diffractive lens exhibiting enhanced optical performance
WO2011005713A3 (en) Visible light absorbers for ophthalmic lens materials
EP2002841A4 (en) OPHTHALMIC COMPOSITION WITH XANTHANGUMMI AND GLUCOSE

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08833950

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009534392

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 12680318

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08833950

Country of ref document: EP

Kind code of ref document: A1